On the other hand, KRAS mutant CRC cells with high activation of canonical Wnt-β-catenin signaling pathway are refractory to MEKi, inhibition of which overcomes resistance and induces cell apoptosis 176. This evidence concerns the gene KRAS and colorectal carcinoma.